A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer
Condition: BRAF V600 Colorectal Cancer Interventions: Drug: Dabrafenib; Drug: LTT462; Drug: Trametinib; Drug: LXH254; Drug: TNO155; Biological: Spartalizumab Sponsor: Novartis Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials